USD 10.52
(-0.8%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 2.02 Billion USD | 30.07% |
2022 | 1.55 Billion USD | -4.85% |
2021 | 1.63 Billion USD | -4.98% |
2020 | 1.72 Billion USD | -38.17% |
2019 | 2.78 Billion USD | 30.07% |
2018 | 2.14 Billion USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 2.09 Billion USD | 0.77% |
2024 Q1 | 2.08 Billion USD | 2.86% |
2024 Q3 | 2.05 Billion USD | -2.31% |
2023 Q4 | 2.02 Billion USD | 2.8% |
2023 Q2 | 1.95 Billion USD | 24.92% |
2023 Q1 | 1.56 Billion USD | 0.32% |
2023 Q3 | 1.97 Billion USD | 0.96% |
2023 FY | 2.02 Billion USD | 30.07% |
2022 Q3 | 1.66 Billion USD | -1.67% |
2022 FY | 1.55 Billion USD | -4.85% |
2022 Q4 | 1.55 Billion USD | -6.7% |
2022 Q2 | 1.69 Billion USD | -0.41% |
2022 Q1 | 1.7 Billion USD | 4.14% |
2021 Q3 | 1.71 Billion USD | -2.95% |
2021 Q4 | 1.63 Billion USD | -4.4% |
2021 FY | 1.63 Billion USD | -4.98% |
2021 Q1 | 1.72 Billion USD | 0.42% |
2021 Q2 | 1.76 Billion USD | 1.99% |
2020 Q2 | 2.8 Billion USD | 4017.58% |
2020 FY | 1.72 Billion USD | -38.17% |
2020 Q3 | 2.88 Billion USD | 2.71% |
2020 Q4 | 1.72 Billion USD | -40.25% |
2020 Q1 | 68.16 Million USD | -97.55% |
2019 Q1 | 101.07 Million USD | 0.0% |
2019 FY | 2.78 Billion USD | 30.07% |
2019 Q4 | 2.78 Billion USD | 0.0% |
2018 FY | 2.14 Billion USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | -39.45 Million USD | 5233.839% |
Applied DNA Sciences, Inc. | -5.91 Million USD | 34347.35% |
Aspira Women's Health Inc. | -331 Thousand USD | 612003.927% |
Biodesix, Inc. | 34.3 Million USD | -5803.757% |
BioNexus Gene Lab Corp. | -5.79 Million USD | 35045.18% |
bioAffinity Technologies, Inc. | -1.24 Million USD | 163053.696% |
bioAffinity Technologies, Inc. | -1.24 Million USD | 163053.696% |
Bionano Genomics, Inc. | 34.88 Million USD | -5706.439% |
CareDx, Inc | -47.97 Million USD | 4321.698% |
Check-Cap Ltd. | -24.75 Million USD | 8281.459% |
Castle Biosciences, Inc. | -83.53 Million USD | 2524.731% |
DarioHealth Corp. | -7.54 Million USD | 26933.625% |
Exact Sciences Corporation | 1.94 Billion USD | -3.902% |
Fulgent Genetics, Inc. | -82.56 Million USD | 2553.07% |
Guardant Health, Inc. | 220.22 Million USD | -819.688% |
ICON Public Limited Company | 3.56 Billion USD | 43.11% |
IDEXX Laboratories, Inc. | 493.94 Million USD | -310.044% |
Illumina, Inc. | 1.21 Billion USD | -66.837% |
Intelligent Bio Solutions Inc. | -5.43 Million USD | 37381.971% |
iSpecimen Inc. | -2.14 Million USD | 94417.838% |
Standard BioTools Inc. | 46.5 Million USD | -4255.141% |
MDxHealth SA | 18.88 Million USD | -10624.925% |
23andMe Holding Co. | -141.37 Million USD | 1532.675% |
Medpace Holdings, Inc. | -103.32 Million USD | 2060.187% |
Myriad Genetics, Inc. | 88.1 Million USD | -2198.981% |
Mainz Biomed B.V. | 349.85 Thousand USD | -578826.127% |
ENDRA Life Sciences Inc. | -2.43 Million USD | 83125.156% |
NeoGenomics, Inc. | 269.19 Million USD | -652.403% |
Neogen Corporation | 735.62 Million USD | -175.33% |
Inotiv, Inc. | 382.14 Million USD | -430.003% |
Natera, Inc. | -200.1 Million USD | 1112.185% |
OpGen, Inc. | 11.89 Million USD | -16931.802% |
OPKO Health, Inc. | 230.68 Million USD | -778.002% |
Psychemedics Corporation | 334 Thousand USD | -606307.784% |
Prenetics Global Limited | -43.33 Million USD | 4773.603% |
Prenetics Global Limited | -43.33 Million USD | 4773.603% |
Precipio, Inc. | -386 Thousand USD | 524815.544% |
Personalis, Inc. | -8.02 Million USD | 25348.093% |
RadNet, Inc. | 1.14 Billion USD | -76.344% |
Sera Prognostics, Inc. | -2.02 Million USD | 100268.249% |
Neuronetics, Inc. | 2.79 Million USD | -72313.371% |
Star Equity Holdings, Inc. | -15.33 Million USD | 13305.986% |
Star Equity Holdings, Inc. | -15.33 Million USD | 13305.986% |
Trinity Biotech plc | 63.73 Million USD | -3077.799% |
T2 Biosystems, Inc. | 33.8 Million USD | -5890.718% |
Twist Bioscience Corporation | -192.4 Million USD | 1152.698% |
Exagen Inc. | -12.77 Million USD | 15958.143% |